Delisting riskPopularity #4,929
LFWD · NASDAQ · Medical - Devices

Lifeward (LFWD)

Powered exoskeletons and anti-gravity treadmills for mobility and rehabilitation.

$6.99
After hours−0.14 (−1.96%)
At close$7.13(+1.78%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue475768566547
Cost of revenue444446333434
Gross profit121322233113
99875117966127
Research & development111111111162
877646665565
Selling & marketing455444443334
General & administrative322202222232
Other expenses000004030000
Operating income−8−6−7−4−3−10−5−7−3−5−10−4
0000−3−60−7000−7
Interest income000000000000
Interest expense000000000000
Other non-operating income00003−40−30007
Income before tax−8−6−6−4−6−15−5−13−3−5−11−12
Income tax expense0000−300−70000
Net income from continuing operations−8−6−6−4−3−15−5−7−3−5−11−12
Net income−8−6−6−4−3−15−5−7−3−5−11−12
EPS, basic−$10.56−$10.92−$8.76−$6.00−$4.20−$20.76−$5.52−$6.96−$2.40−$3.60−$6.70−$4.12
EPS, diluted−$10.56−$10.92−$8.76−$6.00−$4.20−$20.76−$5.52−$6.96−$2.40−$3.60−$6.70−$4.12
Weighted average shares, basic11123
Weighted average shares, diluted11123
EBITDA−7−5−5−3−5−4−5−4−3−5−5−11
Depreciation & amortization111111000050
EBIT−8−6−6−4−6−5−5−4−3−5−10−11